European Archives - Page 625 of 1615 - European Medical Journal

Study Reveals How Type 2 Diabetes Increases Cardiovascular Risks

Study links type 2 diabetes to impaired fibrous repair in atherosclerotic plaques, highlighting new treatment possibilities.

Bimekizumab Offers Breakthrough Relief for Axial Spondyloarthritis

Bimekizumab reduces pain, stiffness, and fatigue in axial spondyloarthritis, offering a transformative option for managing this chronic condition.

Faster, Accurate Endometriosis Diagnosis with New Biomarker Panel

A novel biomarker panel shows promise for non-invasive endometriosis diagnosis, offering faster, more accurate detection.

New Insights into Genomic Biomarkers for Pancreatic Cancer

A study examining over 2,300 patients has unveiled promising new genomic biomarkers that could improve prognosis and treatment strategies for pancreatic ductal adenocarcinoma…

Advanced Imaging Reveals Prostate Cancer More Extensive Than Previously Thought

New imaging technique has shown that many cases of prostate cancer may be more advanced than conventional imaging suggests.

ACG Updates Guidelines For Eosinophilic Oesophagitis Management

The latest clinical guidelines from the American College of Gastroenterology (ACG) aim to improve the diagnosis and treatment of eosinophilic oesophagitis.

Can Online Cognitive Behavioural Therapy Improve Atopic Dermatitis?

Self-guided online CBT is noninferior to clinician-guided CBT for atopic dermatitis, offering effective and resource-efficient treatment.

Pulse Points: Advancing Cardiovascular Medicine

In this episode, Jonathan Sackier is joined by Eric Secemsky, a world-renowned interventional cardiologist whose innovative research and clinical expertise are redefining cardiovascular care.

Limited Value of Routine Follow-Up in Lymphoma Remission

Study reveals limited effectiveness of routine follow-up in detecting relapses in diffuse large B-cell lymphoma patients in remission.

Needle-free vaccine technology wins $3.7m in funding from CEPI

Micron Biomedical, an Atlanta-based life sciences company, has received funding for its technology that could improve vaccine access.